Joining Forces : How to Coordinate Large, Multicenter Randomized Trials - 11/11/21


Résumé |
This article details the pros, cons, challenges/pitfalls, and elements required for the successful conduct of multicenter randomized trials, with specific focus on trials related to pleural diseases. Several networks dedicated to the multicenter study of important pleural conditions have developed, yielding practice-changing studies in pleural disease. This review describes the importance of multicenter trials, major elements required for the conduct of such trials, and lessons learned from the ongoing development of the Interventional Pulmonary Outcomes Group, a consortium of interventional pulmonologists dedicated to advancing diagnostic and management strategies in pleural, pulmonary parenchymal, and airway disease by generating high-quality multicenter evidence.
Le texte complet de cet article est disponible en PDF.Keywords : Clinical trials, Randomized, Multicenter trial, Pleural disease, Research designs
Plan
| Summary COI statement: No authors report any financial or nonfinancial conflicts of interest pertinent to this work. |
|
| Funding information: Nonfunded work. |
|
| Notification of prior publication/presentation: No aspect of this work has been previously published nor is under consideration by any other journals. |
Vol 42 - N° 4
P. 767-776 - décembre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
